Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H1-Antihistamines in Asia, Middle-East and Africa: Results from the AWARE-AMAC study

[1]  M. Labrador-Horrillo,et al.  Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study , 2018, The World Allergy Organization journal.

[2]  F. Bérard,et al.  Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE‐CSU , 2018, Allergy.

[3]  A. Giménez-Arnau,et al.  Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment. , 2018, Acta dermato-venereologica.

[4]  T. Zuberbier,et al.  The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria , 2018, Allergy.

[5]  M. Hide,et al.  Impact of chronic urticaria on quality of life and work in Japan: Results of a real‐world study , 2018, The Journal of dermatology.

[6]  S. Youn,et al.  Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population‐based study , 2018, The Journal of dermatology.

[7]  Ji-Hye Kim,et al.  Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria , 2016, The Korean journal of internal medicine.

[8]  C. Chu,et al.  Epidemiology and comorbidities of patients with chronic urticaria in Taiwan‏: A nationwide population-based study. , 2017, Journal of dermatological science.

[9]  F. Bérard,et al.  The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSU , 2017, Allergy.

[10]  D. Simancas-Racines,et al.  Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador , 2017, The World Allergy Organization journal.

[11]  A. Knulst,et al.  Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria , 2017, Clinical and Translational Allergy.

[12]  M. Rimoldi,et al.  State of the art of chronic spontaneous urticaria in Italy: a multicentre survey to evaluate physicians’ and patients’ perspectives , 2016, BMJ Open.

[13]  C. Chu,et al.  Unmet medical needs for chronic spontaneous urticaria patients: highlighting the real‐life clinical practice in Taiwan , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  A. Knulst,et al.  Work Productivity and Activity Impairment Among Chronic Spontaneous/Idiopathic Urticaria Patients: ResultsFrom The First International Burden of Illness Study (Assure-Csu). , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[15]  J. Vietri,et al.  Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[16]  T. Casale,et al.  Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy. , 2015, The journal of allergy and clinical immunology. In practice.

[17]  T. Zuberbier,et al.  The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.

[18]  P. Kuna,et al.  Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. , 2013, The Journal of allergy and clinical immunology.

[19]  T. Casale,et al.  Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. , 2013, The New England journal of medicine.

[20]  T. Zuberbier,et al.  Management of chronic spontaneous urticaria in real life – in accordance with the guidelines? A cross‐sectional physician‐based survey study , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[21]  T. Zuberbier,et al.  Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective , 2012, The World Allergy Organization journal.

[22]  A. Barbosa,et al.  Chronic idiopathic urticaria and anxiety symptoms , 2011, Journal of health psychology.

[23]  J. Bousquet,et al.  Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1 , 2011, Allergy.

[24]  T. Zuberbier,et al.  Chronic urticaria: a patient survey on quality‐of‐life, treatment usage and doctor–patient relation , 2009, Allergy.

[25]  H. Schünemann,et al.  EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria , 2006, Allergy.

[26]  M. Sticherling,et al.  Chronic urticaria – which clinical parameters are pathogenetically relevant? A retrospective investigation of 339 patients , 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[27]  T. Zuberbier,et al.  EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria , 2006, Allergy.